Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $144.86 -0.83%
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
24 Buy, 13 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
Piper Jaffray upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Neutral to Overweight, price target increased from $10 to $12.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.34 yesterday.
For more ratings news on Alnylam Pharmaceuticals click here and for the rating history of Alnylam Pharmaceuticals click here.
Shares of Alnylam Pharmaceuticals closed at $7.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Tesla (TSLA) to Buy on wind up of positive catalysts
- Mizuho Upgrades Airbnb Inc. (ABNB) to Buy, 'We see opportunities'
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $170 at Morgan Stanley
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
